Blocking of NRP1/S-protein interaction with small-molecule inhibitors or monoclonal antibodies (mAbs) may reduce SARS-CoV-2 infectivity and provide potential intervention strategies for COVID-19 management 62
In November 2025, Novo Nordisk lowered its standard self-pay price for most doses of Wegovy and Ozempic to $349 per month, with a limited-time introductory price of $199 per month for new self-pay patients on the two lowest doses
What the conversation covers Unique challenges in type 1 diabetes , why insulin alone has structural limitations The mechanism , how GLP-1 therapies work The evidence in type 1 diabetes , from early studies to ADJUST T1D and tirzepatide Exploration points , what the evidence tends to show on insulin adjustment, monitoring, and nutrition Future directions , triple and quadruple agonists, reimbursement, and paediatric potential Watch or listen Key themes Why insulin alone has structural limitations The episode opens by exploring why insulin alone has structural limitations in type 1 diabetes
Why Demand for GLP-1 Medications Is Rising The popularity of GLP-1 medications has grown rapidly in recent years
Frequently Asked Questions What is the main difference between Henry Meds and other GLP-1 providers
Allergy 79(12):33733384 Toki S, Zhang J, Printz RL, Newcomb DC, Cahill KN, Niswender KD et al (2023) Dual GIPR and GLP-1R agonist Tirzepatide inhibits aeroallergen-induced allergic airway inflammation in mouse model of obese asthma
:format(webp))
